Tranexamic Acid for Postpartum Hemorrhage Prevention in Vaginal Delivery: A Meta-analysis

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2020 Feb 4

PMID 32011478

Citations 6

Authors

Yimeng Xia

Brian B Griffiths

Qingsheng Xue

Affiliations

Soon will be listed here.

Abstract

Background: Tranexamic acid (TA) has been demonstrated to reduce blood loss and the incidences of postpartum hemorrhage (PPH) during caesarean sections. We compared the clinical efficacy of TA administration on vaginal deliveries with recently published papers.

Methods: Electronic databases of PubMed, Cochrane Library, Embase and Chinese CNKI (Chinese database) and Wanfang were searched through November 2019.The randomized controlled trials were selected between TA and control groups. The relevant studies included four trials with a total of 4579 patients.

Results: Patients treated with TA had a reduction in total blood loss (P = .009), lower postoperative blood loss (P < .00001), a reduced number of PPH (P = .02). However, the occurrence of nausea or/and vomiting is higher in the TA group (the incidence of nausea or vomiting [P < .00001], nausea [P < .00001] and vomiting [P < .00001]).

Conclusion: TA resulted in fewer occurrence rates of PPH, and no significant increase in occurrences of dizziness or photopsia, but higher incidence of vomiting and nausea.

Citing Articles

Hemostatic effect of oxidized regenerated cellulose vs. topical tranexamic acid in total knee arthroplasty-a prospective randomized controlled trial.

Li B, Pan W, Ma J, Huang Y Front Surg. 2025; 11():1515610.

PMID: 39840260 PMC: 11747695. DOI: 10.3389/fsurg.2024.1515610.

Systemic vs. in-irrigation tranexamic acid in percutaneous nephrolithotomy A systematic review, Bayesian network meta-analysis, and meta-regression.

Hinojosa-Gonzalez D, Somani B, Olvera-Posada D, Segall M, Villanueva-Congote J, Eisner B Can Urol Assoc J. 2024; 18(9):E285-E290.

PMID: 39190177 PMC: 11404680. DOI: 10.5489/cuaj.8721.

Tranexamic acid for the prevention and treatment of postpartum hemorrhage in resource-limited settings: a literature review.

Gedeno Gelebo K, Mulugeta H, Mossie A, Geremu K, Darma B Ann Med Surg (Lond). 2024; 86(1):353-360.

PMID: 38222769 PMC: 10783298. DOI: 10.1097/MS9.0000000000001560.

Intravenous Tranexamic acid versus placebo during Caesarian section: A comparative study.

Iqbal M, Mazhar A, Shabir A Pak J Med Sci. 2022; 38(5):1183-1187.

PMID: 35799760 PMC: 9247800. DOI: 10.12669/pjms.38.5.5383.

Does Tranexamic Acid Reduce the Blood Loss in Various Surgeries? An Umbrella Review of State-of-the-Art Meta-Analysis.

Hong P, Liu R, Rai S, Liu J, Ding Y, Li J Front Pharmacol. 2022; 13:887386.

PMID: 35662737 PMC: 9160460. DOI: 10.3389/fphar.2022.887386.

References

Dunn C, Goa K . Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999; 57(6):1005-32. DOI: 10.2165/00003495-199957060-00017. View

Mantel G, Buchmann E, Rees H, Pattinson R . Severe acute maternal morbidity: a pilot study of a definition for a near-miss. Br J Obstet Gynaecol. 1998; 105(9):985-90. DOI: 10.1111/j.1471-0528.1998.tb10262.x. View

Ducloy-Bouthors A, Jude B, Duhamel A, Broisin F, Huissoud C, Keita-Meyer H . High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care. 2011; 15(2):R117. PMC: 3219400. DOI: 10.1186/cc10143. View

Zargar M, Nikbakht R, Ahmadi M . The Effect of Tranexamic Acid on Preventing Post-partum Hemorrhage Due to Uterine Atony: A Triple-blind Randomized Clinical Trial. Curr Clin Pharmacol. 2018; 13(2):136-139. DOI: 10.2174/1574884713666180507101002. View

Cheriyan T, Maier 2nd S, Bianco K, Slobodyanyuk K, Rattenni R, Lafage V . Efficacy of tranexamic acid on surgical bleeding in spine surgery: a meta-analysis. Spine J. 2015; 15(4):752-61. DOI: 10.1016/j.spinee.2015.01.013. View

Shaaban M, Ahmed M, Farhan R, Dardeer H . Efficacy of Tranexamic Acid on Myomectomy-Associated Blood Loss in Patients With Multiple Myomas: A Randomized Controlled Clinical Trial. Reprod Sci. 2016; 23(7):908-12. DOI: 10.1177/1933719115623646. View

Wesley M, Pereira L, Scharp L, Emani S, McGowan Jr F, DiNardo J . Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. Anesthesiology. 2015; 122(4):746-58. DOI: 10.1097/ALN.0000000000000570. View

Mirghafourvand M, Mohammad-Alizadeh S, Abbasalizadeh F, Shirdel M . The effect of prophylactic intravenous tranexamic acid on blood loss after vaginal delivery in women at low risk of postpartum haemorrhage: a double-blind randomised controlled trial. Aust N Z J Obstet Gynaecol. 2015; 55(1):53-8. DOI: 10.1111/ajo.12262. View

Alam A, Bopardikar A, Au S, Barrett J, Callum J, Kiss A . Protocol for a pilot, randomised, double-blinded, placebo-controlled trial of prophylactic use of tranexamic acid for preventing postpartum haemorrhage (TAPPH-1). BMJ Open. 2017; 7(10):e018586. PMC: 5652619. DOI: 10.1136/bmjopen-2017-018586. View

10.

Karoshi M, Keith L . Challenges in managing postpartum hemorrhage in resource-poor countries. Clin Obstet Gynecol. 2009; 52(2):285-98. DOI: 10.1097/GRF.0b013e3181a4f737. View

11.

Sentilhes L, Daniel V, Darsonval A, Deruelle P, Vardon D, Perrotin F . Study protocol. TRAAP - TRAnexamic Acid for Preventing postpartum hemorrhage after vaginal delivery: a multicenter randomized, double-blind, placebo-controlled trial. BMC Pregnancy Childbirth. 2015; 15:135. PMC: 4465316. DOI: 10.1186/s12884-015-0573-5. View

12.

Montufar-Rueda C, Rodriguez L, Jarquin J, Barboza A, Bustillo M, Marin F . Severe postpartum hemorrhage from uterine atony: a multicentric study. J Pregnancy. 2013; 2013:525914. PMC: 3864080. DOI: 10.1155/2013/525914. View

13.

Sentilhes L, Winer N, Azria E, Senat M, LE Ray C, Vardon D . Tranexamic Acid for the Prevention of Blood Loss after Vaginal Delivery. N Engl J Med. 2018; 379(8):731-742. DOI: 10.1056/NEJMoa1800942. View

14.

Driessen M, Bouvier-Colle M, Dupont C, Khoshnood B, Rudigoz R, Deneux-Tharaux C . Postpartum hemorrhage resulting from uterine atony after vaginal delivery: factors associated with severity. Obstet Gynecol. 2010; 117(1):21-31. PMC: 3319503. DOI: 10.1097/AOG.0b013e318202c845. View

15.

Gertler R, Gruber M, Grassin-Delyle S, Urien S, Martin K, Tassani-Prell P . Pharmacokinetics of tranexamic acid in neonates and infants undergoing cardiac surgery. Br J Clin Pharmacol. 2017; 83(8):1745-1757. PMC: 5510067. DOI: 10.1111/bcp.13274. View

16.

Abdel-Aleem H, Alhusaini T, Abdel-Aleem M, Menoufy M, Gulmezoglu A . Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. J Matern Fetal Neonatal Med. 2013; 26(17):1705-9. DOI: 10.3109/14767058.2013.794210. View

17.

Zhang W, Alexander S, Bouvier-Colle M, Macfarlane A . Incidence of severe pre-eclampsia, postpartum haemorrhage and sepsis as a surrogate marker for severe maternal morbidity in a European population-based study: the MOMS-B survey. BJOG. 2005; 112(1):89-96. DOI: 10.1111/j.1471-0528.2004.00303.x. View

18.

Fawcus S, Moodley J . Postpartum haemorrhage associated with caesarean section and caesarean hysterectomy. Best Pract Res Clin Obstet Gynaecol. 2012; 27(2):233-49. DOI: 10.1016/j.bpobgyn.2012.08.018. View

19.

Shakur H, Elbourne D, Gulmezoglu M, Alfirevic Z, Ronsmans C, Allen E . The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials. 2010; 11:40. PMC: 2864262. DOI: 10.1186/1745-6215-11-40. View

20.

Al Wattar B, Tamblyn J, Parry-Smith W, Prior M, van der Nelson H . Management of obstetric postpartum hemorrhage: a national service evaluation of current practice in the UK. Risk Manag Healthc Policy. 2017; 10:1-6. PMC: 5261839. DOI: 10.2147/RMHP.S121737. View